$SIBN

Davis Timothy E JR sold $55K of SIBN

Davis Timothy E JR sold 3,780 shares of SI-BONE, Inc. (SIBN) at $14.47 on 2026-05-28.

Original reporting
SEC EDGAR · Davis Timothy E JR
Published Jun 1, 2026, 9:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SIBN
Neutral
medium confidence
Mentioned
$SIBN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

Provides a dated datapoint on insider behavior; useful for sentiment/positioning but not a standalone fundamental catalyst.

02

Market read

Traders may use the disclosure to gauge insider sentiment, but the lack of accompanying operational/financial news limits immediate trading impact.

03

What to watch

Check whether there is a cluster of insider sales around the same period or any concurrent corporate news not mentioned in this brief.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 1; sale executed May 28

Background

The article is an SEC Form 4 insider transaction disclosure (director open-market sale).

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SI-BONE director Timothy E. Davis sold $54.7K of SIBN shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; watch for follow-on insider activity or broader sentiment shifts.

Evidence & confidence

The filing provides a concrete transaction and price, but insider sales alone rarely drive large moves unless part of a pattern or accompanied by other company-specific catalysts.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst stated.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; absence of a 10b5-1 plan does not automatically imply negative fundamentals.

Key entities

  • SI-BONE, Inc.

    Public company whose director disclosed an open-market sale of shares via SEC Form 4.

  • Timothy E. Davis Jr.

    Director who sold 3,780 shares at $14.4706 on May 28, 2026.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q